Negotiating fees with auditors
Assessing profitability of various products
Evaluating the costs and benefits of a new product design
2. Based on this table and your understanding of the two roles, what types of training or
experience will George find most useful for the CFO position?
SOLUTION
(15 min.) Role of controller, role of chief financial officer.
1.
Activity Controller CFO
Managing the company’s long-term investments X
Presenting financial statements to the board of directors X
Strategic review of different lines of businesses X
Budgeting funds for a plant upgrade X
Managing accounts receivable X
Negotiating fees with auditors X
Assessing profitability of various products X
Evaluating the costs and benefits of a new product design X
2. As CFO, Jimenez will be interacting much more with the senior management of the
company, the board of directors, auditors, and the external financial community. Any experience
he can get with these aspects will help him in his new role as CFO. George Jimenez can be better
positioned for his new role as CFO by participating in strategy discussions with senior
management, by preparing the external investor communications and press releases under the
guidance of the current CFO, by attending courses that focus on the interaction and negotiations
between the various business functions and outside parties such as auditors and, either formally
or on the job, getting training in issues related to investments and corporate finance.
1-34 Budgeting, ethics, pharmaceutical company. Chris Jackson was recently promoted to
Controller of Research and Development (R&D) for BrisCor, a Fortune 500 pharmaceutical
company that manufactures prescription drugs and nutritional supplements. The company’s total
R&D cost for 2017 was expected (budgeted) to be $5 billion. During the company’s midyear
budget review, Chris realized that current R&D expenditures were already at $3.5 billion, nearly
40% above the midyear target. At this current rate of expenditure, the R&D division was on track
to exceed its total year-end budget by $2 billion!
In a meeting with CFO Ronald Meece later that day, Jackson delivered the bad news.
Meece was both shocked and outraged that the R&D spending had gotten out of control. Meece
wasn’t any more understanding when Jackson revealed that the excess cost was entirely related
to research and development of a new drug, Vyacon, which was expected to go to market next
year. The new drug would result in large profits for BrisCor, if the product could be approved by
year-end.
1-?